| Dr Jagprit Singh Dhillon, MD | |
|
335 Glessner Ave, Mansfield, OH 44903-2269 | |
| (216) 924-1151 | |
| Not Available |
| Full Name | Dr Jagprit Singh Dhillon |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 335 Glessner Ave, Mansfield, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033156989 | NPI | - | NPPES |
| 2021369 | Medicaid | OH | |
| 110155097 | Other | OH | MEDICARE RR-GA |
| 942460636073 | Other | OH | CARESOURCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35.070181 (Ohio) | Secondary |
| 207P00000X | Emergency Medicine | 35070181D (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
| University Hospitals - Elyria Medical Center | Elyria, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-ohio Emergency Group, Llc | 7810233517 | 43 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Physicians Link Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172925 PECOS PAC ID: 8527969492 Enrollment ID: O20040405000838 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Ues Richmond Heights Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568414613 PECOS PAC ID: 8224057047 Enrollment ID: O20051122000004 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Ues Geauga, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841242997 PECOS PAC ID: 6406876002 Enrollment ID: O20051128000779 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Mid Ohio Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548490790 PECOS PAC ID: 4880730167 Enrollment ID: O20090930000610 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Ues Ahuja Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467883934 PECOS PAC ID: 5496985467 Enrollment ID: O20140313001425 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Magis Emergency Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801287511 PECOS PAC ID: 2769700392 Enrollment ID: O20150410002555 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Entity Name | Mid-ohio Emergency Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881164010 PECOS PAC ID: 7810233517 Enrollment ID: O20190117001823 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jagprit Singh Dhillon, MD 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Jagprit Singh Dhillon, MD 335 Glessner Ave, Mansfield, OH 44903-2269 Ph: (216) 924-1151 |
News Archive
Scientists at Johns Hopkins have developed a mouse model for schizophrenia in which a mutated gene linked to schizophrenia can be turned on or off at will.
RNA interference (RNAi) represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, Number 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.
Researchers at Duke University Medical Center appear to have solved at least a piece of a puzzle that has mystified physicians for years: why so many patients with asthma also suffer from GERD, or gastroesophageal reflux disease.
› Verified 8 days ago
James W Catalano, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 330-493-4443 | |
William R Elliott, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1827 Riva Ridge Dr, Mansfield, OH 44904 Phone: 419-617-4452 Fax: 419-617-1080 | |
Pratik Patel, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 740-383-8473 Fax: 740-383-8695 | |
Bradley Gehring, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8000 | |
George A Snicer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 330-493-4443 Fax: 330-493-8677 | |
Anthony J Midkiff, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 330-493-4443 | |
Joshua Allen Caldwell, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 617 Springmill St, Mansfield, OH 44903 Phone: 561-274-2748 |